Polymorphisms of the tumour necrosis factor‐α gene, coronary heart disease and obesity

Tumour necrosis factor‐α (TNF‐α) is a cytokine that has multiple functions. Through its effects on lipid metabolism, coagulation, insulin resistance and endothelial function, TNF‐α could be involved in cardiovascular pathophysiology. Given this possibility, we hypothesized that polymorphisms of the TNF‐α gene might be associated with a predisposition to coronary heart disease (CHD).

[1]  H. Shepard,et al.  Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α , 1987, Nature.

[2]  M. Lopes-Virella,et al.  Atherosclerosis and autoimmunity. , 1994, Clinical immunology and immunopathology.

[3]  M. Nei.  Molecular Evolutionary Genetics , 1987 .

[4]  M. Kornitzer,et al.  The World Health Organization MONICA Project (Monitoring trends and determinants in cardiovascular disease): A major international Collaboration , 1988 .

[5]  M. Feldmann,et al.  Functional activities of receptors for tumor necrosis factor-alpha on human vascular endothelial cells. , 1994, Blood.

[6]  H. Mcdevitt,et al.  Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[7]  V. Arshavsky,et al.  cGMP binding sites on photoreceptor phosphodiesterase: role in feedback regulation of visual transduction. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[8]  K. Feingold,et al.  Role of Cytokines in Inducing Hyperlipidemia , 1992, Diabetes.

[9]  W. Fiers,et al.  Two distinct monokines, interleukin 1 and tumor necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells. , 1986, Journal of immunology.

[10]  A. Evans,et al.  A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM Study. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[11]  J. Blackwell,et al.  Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis , 1995, The Journal of experimental medicine.

[12]  D. Stern,et al.  Modulation of endothelial cell hemostatic properties by tumor necrosis factor , 1986, The Journal of experimental medicine.

[13]  J. Mehta,et al.  Increased secretion of tumor necrosis factor-alpha and interferon-gamma by mononuclear leukocytes in patients with ischemic heart disease. Relevance in superoxide anion generation. , 1994, Circulation.

[14]  M. Giphart,et al.  THE EUROTRANSPLANT HLA‐DRB OLIGONUCLEOTIDE TYPING SET , 1991, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[15]  D. Arveiler,et al.  Factor VII Arg/Gln353 polymorphism determines factor VII coagulant activity in patients with myocardial infarction (MI) and control subjects in Belfast and in France but is not a strong indicator of MI risk in the ECTIM study. , 1996, Atherosclerosis.

[16]  T. Sekiya,et al.  Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[17]  B. Spiegelman,et al.  Tumor necrosis factor alpha inhibits signaling from the insulin receptor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[18]  N. Matthews.  Tumour-necrosis factor from the rabbit. II. Production by monocytes. , 1978, British Journal of Cancer.

[19]  A. Evans,et al.  Genetic variation at the beta-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction. The ECTIM Study. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[20]  F. Pociot,et al.  An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles , 1993, The Journal of experimental medicine.

[21]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[22]  M. Feldmann,et al.  Functional activities of receptors for tumor necrosis factor-alpha on human vascular endothelial cells , 1994 .

[23]  E. Ravussin,et al.  Linkage between obesity and a marker near the tumor necrosis factor-alpha locus in Pima Indians. , 1995, The Journal of clinical investigation.

[24]  D. C. Rao,et al.  Estimation of myriad haplotype frequencies , 1985, Genetic epidemiology.

[25]  B. Spiegelman,et al.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.

[26]  D. Goeddel,et al.  Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization. , 1985, Nucleic acids research.

[27]  L. Old,et al.  Tumor necrosis factor (TNF). , 1985, Science.

[28]  Henry A. Erlich,et al.  Analysis of enzymatically amplified β-globin and HLA-DQα DNA with allele-specific oligonucleotide probes , 1986, Nature.

[29]  D. Arveiler,et al.  Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The ECTIM Study. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[30]  L. V. D. van de Putte,et al.  A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha , 1994, European journal of immunology.

[31]  B. Beutler,et al.  Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells , 1985, The Journal of experimental medicine.

[32]  R. Eckel,et al.  Tumor necrosis factor-alpha eliminates binding of NF-Y and an octamer-binding protein to the lipoprotein lipase promoter in 3T3-L1 adipocytes. , 1995, The Journal of clinical investigation.

[33]  H. Koeffler,et al.  Recombinant human TNF induces production of granulocyte–monocyte colony-stimulating factor , 1986, Nature.

[34]  J. Tavernier,et al.  Multiple effects of tumor necrosis factor on lipoprotein lipase in vivo. , 1987, The Journal of biological chemistry.

[35]  H. Orr,et al.  Linkage map of the human major histocompatibility complex including the tumor necrosis factor genes. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[36]  T. Arakawa,et al.  Molecular weight of recombinant human tumor necrosis factor-alpha. , 1987, The Journal of biological chemistry.

[37]  Principal Investigators,et al.  The World Health Organization MONICA project (monitoring trends and determinants in cardiovascular disease): a major international collabaration , 1988 .

[38]  C. Mantzoros,et al.  Genetic Variability in the TNF-α Promoter Is Not Associated with Type II Diabetes Mellitus (NIDDM) , 1995 .

[39]  B. Beutler,et al.  Cachectin and tumour necrosis factor as two sides of the same biological coin , 1986, Nature.

[40]  J. Mehta,et al.  Increased Secretion of Tumor Necrosis Factor‐α and Interferon‐γ by Mononuclear Leukocytes in Patients With Ischemic Heart Disease Relevance in Superoxide Anion Generation , 1994 .

[41]  J. Bonnet,et al.  Regulation of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 in human vascular smooth muscle cells. , 1994, Circulation research.

[42]  D. Kwiatkowski,et al.  Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria , 1994, Nature.

[43]  B. Spiegelman,et al.  Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. , 1995, The Journal of clinical investigation.

[44]  R. Simsolo,et al.  The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. , 1995, The Journal of clinical investigation.

[45]  A. Cerami,et al.  Studies of endotoxin-induced decrease in lipoprotein lipase activity , 1981, The Journal of experimental medicine.

[46]  D. Goeddel,et al.  Human tumor necrosis factor. Production, purification, and characterization. , 1985, The Journal of biological chemistry.

[47]  Klaus P. Ratzmann Dr..  Insulin resistance in man , 2004, Diabetologia.

[48]  L Tiret,et al.  Reliability of reported family history of myocardial infarction. , 1993, BMJ.

[49]  B. Spiegelman,et al.  IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance , 1996, Science.

[50]  S. Humphries,et al.  The 4G/5G Genetic Polymorphism in the Promoter of the Plasminogen Activator Inhibitor-1 (PAI-1) Gene Is Associated with Differences in Plasma PAI-1 Activity but not with Risk of Myocardial Infarction in the ECTIM Study , 1995, Thrombosis and Haemostasis.

[51]  J. Gabrilove,et al.  Tumor necrosis factor and the acute metabolic response to tissue injury in man. , 1988 .

[52]  M. Fishbein,et al.  Detection and localization of tumor necrosis factor in human atheroma. , 1990, The American journal of cardiology.